The integrated discipline

Bioelectric regeneration. Endogenic pharmacology.
One platform.

The field tells cells where to act. The bioregulator tells cells what to make. Together they form the next axis of regenerative medicine — built on five decades of peer-reviewed work and organized here as a single coherent reference.

Live · Field console
Frequency
Field strength
Indication
Aged skin
Response
Collagen synthesis

→ Phenotype output

Osteogenesis · Angiogenesis · Anti-inflammation · Dedifferentiation · Pattern restoration

01· Field

Pulsed EMF arrives

02· Membrane

A2A / A3 receptors

A2AA3Ca²⁺ influx
03· Mitochondrion

Mitohormesis

04· Nucleus

Transcription

The mechanism

From field to phenotype, in four steps.

The signaling pathway is fully characterized in peer-reviewed literature. The field arrives. The membrane transduces through adenosine A2A and A3 receptors. The mitochondria respond with hormetic ATP and ROS. The nucleus activates the canonical Wnt/β-catenin–Runx2–BMP2 program — the same gates the bioregulators of endogenic pharmacology have always targeted.


Featured · Foundational reference

Five decades. Five named foundations. One integrated discipline.

Robert Becker's regeneration current at SUNY Upstate. Vladimir Khavinson's peptide bioregulator literature at the Saint Petersburg Institute. The FDA's 1979 approval of pulsed electromagnetic field stimulation for non-union bone. Gerald Pollack's exclusion-zone water at the University of Washington. Michael Levin's morphogenetic code at Tufts. Organized here as one platform.


The combination

Each modality alone has limits.
Together they have none.

Bioregulators alone are pure chemistry — they bind, activate, and diffuse, with no spatial control. Pulsed electromagnetic fields alone are pure context — they prime, gate, and pattern, with no cargo. Bioelectric regeneration completes endogenic pharmacology. Endogenic pharmacology completes bioelectric regeneration.

Peptides alone

Tells cells what to make

  • · Transcription factors
  • · Telomerase induction
  • · Tissue-specific signal
Limit: chemistry only
  • No spatial control
  • No pattern memory
  • No mitochondrial lever
PEMF alone

Tells cells where + when

  • · Bioelectric pattern
  • · Mitochondrial drive
  • · Membrane voltage
Limit: no cargo
  • Cell makes whatever it has the genes for
  • Slow on its own
Peptide + EMF

What + where + when

  • · Field opens the gate
  • · Peptide enters primed cell
  • · Pattern guides outcome
Synergy not addition
  • Cell receptive when peptide arrives
  • No one else has both

The discipline

Bioelectric regeneration.

The science. Studies how structured pulsed electromagnetic fields prime cellular machinery — opening ion channels, modulating mitochondria, restoring bioelectric pattern, and conditioning the structured-water substrate. Built on the Becker–Levin lineage at SUNY Upstate and Tufts.

Learn more →
The chemistry partner

Endogenic pharmacology.

The cargo. Short peptide bioregulators of two to seven amino acids that arrive in primed cells and modulate gene expression from within the body's own regulatory architecture. Khavinson lineage, extended through proprietary Ac-X-NH2 dual- terminus modified analogs.

Learn more →
The platform

The instrument.

A tri-axis Helmholtz coil array with embedded near-infrared emitters and integrated bioregulator-delivery synchronization — runs the four-layer field protocol and the paired peptide cargo in a single calibrated session.

Learn more →

Bioelectric regeneration and endogenic pharmacology are halves of one platform. The field opens what the bioregulator was always meant to enter — a primed cell, ready to act on the instructions that short peptides carry. We are honored to organize the integrated discipline and to provide its canonical reference.
Daniel William Dorsey and Daniel Nowak
Founders, Atumnus, Inc.